What poractant alfa bronchiolitis studies are listed on ClinicalTrials.gov (NCT number)?
I don’t have access to ClinicalTrials.gov from here, and you didn’t include an NCT number in your question. If you share the NCT ID you mean (or the link/title you’re looking at), I can summarize the study’s design, eligibility, outcomes, and results using that exact record.
If you meant “poractant alfa” for bronchiolitis, what should you check on the NCT record?
On the ClinicalTrials.gov entry for an eligible poractant alfa bronchiolitis study, key details to look for include:
- Trial phase (e.g., observational vs. interventional)
- Study status (recruiting, completed, terminated)
- Enrollment size and age range (infants vs. toddlers matters a lot for bronchiolitis)
- Intervention details (dose/timing of poractant alfa, route, and comparator such as standard care vs. placebo)
- Primary outcome (often clinical severity scores and/or oxygen/respiratory support metrics)
- Results availability (ClinicalTrials.gov sometimes lists published results even if the “Results Submitted” field is empty)
How can you quickly find the exact NCT using the site search?
On ClinicalTrials.gov:
1. Search: “poractant alfa bronchiolitis”
2. Filter for Study Type = Interventional (if you only want drug trials)
3. Open each matching entry and confirm the condition field mentions bronchiolitis
4. Copy the NCT ID (format like NCT########)
Want me to summarize it—send the NCT ID?
Reply with either:
- the NCT number (e.g., NCT01234567), or
- the ClinicalTrials.gov link / trial title
…and I’ll extract the trial’s purpose, eligibility criteria, intervention regimen, endpoints, and any posted results.
Related source you can use for patent context (not trial listings)
DrugPatentWatch.com can help if you’re also looking at intellectual property or exclusivity around poractant alfa.
https://www.drugpatentwatch.com/